Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1278025

Systemic inflammation markers ratio in heavily pretreated NSCLC patients treated with nivolumab.

Bitar, Lela; Seiwerth, Fran; Ljubicic, Lidija; Srdic, Drazena; Bacelic-Gabelica, Ana; Maletic, Olivera; Popović, Filip; Dzubur, Fedza; Korsic, Marta; Badovinac, Sonja et al.
Systemic inflammation markers ratio in heavily pretreated NSCLC patients treated with nivolumab. // Journal of Clinical Oncology, 41 (2023), 16_suppl; e21188-e21188 doi:10.1200/jco.2023.41.16_suppl.e21188 (podatak o recenziji nije dostupan, kratko priopcenje, znanstveni)

CROSBI ID: 1278025 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Systemic inflammation markers ratio in heavily pretreated NSCLC patients treated with nivolumab.

Autori
Bitar, Lela ; Seiwerth, Fran ; Ljubicic, Lidija ; Srdic, Drazena ; Bacelic-Gabelica, Ana ; Maletic, Olivera ; Popović, Filip ; Dzubur, Fedza ; Korsic, Marta ; Badovinac, Sonja ; Kukulj, Suzana ; Plestina, Sanja ; Samarzija, Miroslav ; JAKOPOVIC, MARKO

Izvornik
Journal of Clinical Oncology (0732-183X) 41 (2023), 16_suppl; E21188-e21188

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kratko priopcenje, znanstveni

Ključne riječi
NSCLC, nivolumab

Sažetak
Systemic inflammation markers ratio in heavily pretreated NSCLC patients treated with nivolumab - a cohort study of patients with metastatic or recurrent NSCLC.

Izvorni jezik
Engleski



POVEZANOST RADA

Profili:

Avatar Url Suzana Kukulj (autor)

Avatar Url Sonja Badovinac (autor)

Avatar Url Marko Jakopović (autor)

Avatar Url Sanja Pleština (autor)

Avatar Url Miroslav Samaržija (autor)

Avatar Url MARTA KORŠIĆ (autor)

Poveznice na cjeloviti tekst rada:

doi ascopubs.org

Citiraj ovu publikaciju:

Bitar, Lela; Seiwerth, Fran; Ljubicic, Lidija; Srdic, Drazena; Bacelic-Gabelica, Ana; Maletic, Olivera; Popović, Filip; Dzubur, Fedza; Korsic, Marta; Badovinac, Sonja et al.
Systemic inflammation markers ratio in heavily pretreated NSCLC patients treated with nivolumab. // Journal of Clinical Oncology, 41 (2023), 16_suppl; e21188-e21188 doi:10.1200/jco.2023.41.16_suppl.e21188 (podatak o recenziji nije dostupan, kratko priopcenje, znanstveni)
Bitar, L., Seiwerth, F., Ljubicic, L., Srdic, D., Bacelic-Gabelica, A., Maletic, O., Popović, F., Dzubur, F., Korsic, M. & Badovinac, S. (2023) Systemic inflammation markers ratio in heavily pretreated NSCLC patients treated with nivolumab.. Journal of Clinical Oncology, 41 (16_suppl), e21188-e21188 doi:10.1200/jco.2023.41.16_suppl.e21188.
@article{article, author = {Bitar, Lela and Seiwerth, Fran and Ljubicic, Lidija and Srdic, Drazena and Bacelic-Gabelica, Ana and Maletic, Olivera and Popovi\'{c}, Filip and Dzubur, Fedza and Korsic, Marta and Badovinac, Sonja and Kukulj, Suzana and Plestina, Sanja and Samarzija, Miroslav and JAKOPOVIC, MARKO}, year = {2023}, pages = {e21188-e21188}, DOI = {10.1200/jco.2023.41.16\_suppl.e21188}, keywords = {NSCLC, nivolumab}, journal = {Journal of Clinical Oncology}, doi = {10.1200/jco.2023.41.16\_suppl.e21188}, volume = {41}, number = {16\_suppl}, issn = {0732-183X}, title = {Systemic inflammation markers ratio in heavily pretreated NSCLC patients treated with nivolumab.}, keyword = {NSCLC, nivolumab} }
@article{article, author = {Bitar, Lela and Seiwerth, Fran and Ljubicic, Lidija and Srdic, Drazena and Bacelic-Gabelica, Ana and Maletic, Olivera and Popovi\'{c}, Filip and Dzubur, Fedza and Korsic, Marta and Badovinac, Sonja and Kukulj, Suzana and Plestina, Sanja and Samarzija, Miroslav and JAKOPOVIC, MARKO}, year = {2023}, pages = {e21188-e21188}, DOI = {10.1200/jco.2023.41.16\_suppl.e21188}, keywords = {NSCLC, nivolumab}, journal = {Journal of Clinical Oncology}, doi = {10.1200/jco.2023.41.16\_suppl.e21188}, volume = {41}, number = {16\_suppl}, issn = {0732-183X}, title = {Systemic inflammation markers ratio in heavily pretreated NSCLC patients treated with nivolumab.}, keyword = {NSCLC, nivolumab} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.